Showing results (1-10 of 101) with videos related to
Sort By:
Pageof 11
Trends in Endocrinology and Metabolism: TEM|April 9, 2014
FGF21-based pharmacotherapy--potential utility for metabolic disordersRuth E Gimeno, David E MollerJournal of Lipid Research|July 29, 2008
Thematic review series: glycerolipids. Mammalian glycerol-3-phosphate acyltransferases: new genes for an old activityRuth E Gimeno, Jingsong CaoCell Metabolism|January 10, 2012
Metabolic disease drug discovery- "hitting the target" is easier said than doneDavid E MollerCell Metabolism|February 11, 2016
The Sweetest Thing: Regulation of Macronutrient Preference by FGF21Andrew C Adams, Ruth E GimenoCurrent Opinion in Pharmacology|March 23, 2005
Adipose tissue as an active endocrine organ: recent advancesRuth E Gimeno, Lori D KlamanAnnual Review of Medicine|January 31, 2002
The mechanisms of action of PPARsJoel Berger, David E MollerCell Metabolism|March 19, 2020
Leveraging the Gut to Treat Metabolic DiseaseRuth E Gimeno, Daniel A Briere, Randy J SeeleyAnnual Review of Medicine|January 22, 2005
Metabolic syndrome: a clinical and molecular perspectiveDavid E Moller, Keith D KaufmanEndocrine|April 20, 2006
Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndromeJun Kusunoki, Akio Kanatani, David E MollerPageof 11